Groenlandicine, a protoberberine alkaloid, is a cholinesterase inhibitor (AChE (IC50 = 0.54 µM), BChE (IC50 = 3.32 µM)). Groenlandicine non-competitively inhibits BACE1 (IC50 = 19.68 µM, Ki = 21.2) and inhibits RLAR (IC50 = 140.1 µM), HRAR (IC50 = 154.2 µM), and total ROS generation (IC50 = 51.78 µM) in vitro. Groenlandicine suppresses osteosarcoma cell proliferation while promoting apoptosis. Groenlandicine inhibits the tumor growth when combined with Cisplatin (HY-17394). Groenlandicine can be used for the study on osteosarcoma, Alzheimers disease and diabetes mellitus [1][2][3][4][5].
Molekulargewicht:
322.34
Reinheit:
99.87
CAS Nummer:
[38691-95-1]
Formel:
C19H16NO4+
Target-Kategorie:
Apoptosis,Beta-secretase,Cholinesterase (ChE),Reactive Oxygen Species (ROS),Topoisomerase
Anwendungsbeschreibung:
Natural Products
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
